On Wednesday, BofA Securities maintained its Buy rating on Dr. Reddy's Laboratories Ltd. (DRRD:IN) (NYSE: RDY) stock with a steady price target of INR1,530.00. The firm's assessment follows Dr ...

By Wilson Wong In his latest book, the Rolling Stone writer David Browne tracks three decades of folk, blues, rock and jazz below 14th Street. By Peter Keepnews A Poem About Waiting, and Wishing ...

This advertisement has not loaded yet, but your article continues below. Police exchanged gunfire with the man, which left him and an officer wounded Samples are on their way to Winnipeg's ...

SHOPPING: Time to ditch the bulky laundry jugs in favor of these eco-friendly, ultra-concentrated strips that save space, money, AND the planet-and they're available in a variety of scents ...

On Wednesday, BofA Securities maintained its Buy rating on Dr. Reddy's Laboratories Ltd. (DRRD:IN) (NYSE: RDY) stock with a steady price target of INR1,530.00. The firm's assessment follows Dr.

Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world ...